TAK SG&A Expense Growth
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) · SG&A Expense Growth
TAK SG&A Expense Growth
Latest reported4.06%period ending
TAK FY SG&A Growth (YoY) (0.00% → 4.06%)
Latest values, visible window
High-resolution chart · PNG
TAK sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 4.0584% | |
| 4.8345% | |
| 5.6662% | |
| 12.5172% | |
| 1.2217% | |
| -9.233% | |
| 34.4396% | |
| 14.2481% | |
| 1.4611% | |
| -4.873% | |
| 6.2291% | |
| 10.1406% | |
| -43.6541% | |
| 21.7615% | |
| 10.343% | |
| -3.414% | |
| -19.2753% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -100% | |
| 0% | |
| -100% | |
| 0% |